Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
dupilumab
Pharma
Dupixent data enhance Sanofi, Regeneron's pursuit of COPD nod
Sanofi and Regeneron provided trial results which bolster their pursuit of an FDA approval to treat chronic obstructive pulmonary disease.
Kevin Dunleavy
May 20, 2024 2:24pm
Sanofi, Regeneron enlist 'The Night Of' creator for AD awareness
Oct 30, 2017 10:05am
After a slow 2016, FDA's racking up drug approvals lickety-split
Jun 26, 2017 9:14am
Regeneron misses Q1 amid slowing sales of Eylea
May 4, 2017 12:05pm
Amgen slaps Sanofi, Regeneron with Dupixent lawsuit
Apr 20, 2017 8:37am
Dupixent's $37K price may be right: analysts
Mar 29, 2017 7:24am
